ARYL- AND HETEROARYL SUBSTITUTED CHK1 INHIBITORS AND THEIR USE AS RADIOSENSITIZERS AND CHEMOSENSITIZERS

Aryl- and heteroaryl substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized...

Full description

Saved in:
Bibliographic Details
Main Authors COOK ADAM WADE, BURGESS LAURENCE EDWARD, GAUDINO JOHN JOSEPH, KEEGAN KATHLEEN S, COWEN SCOTT DOUGLAS, KESICKI EDWARD A
Format Patent
LanguageEnglish
Published 16.10.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Aryl- and heteroaryl substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed. Wherein W is a six-membered aromatic ring containing at least 2 introgen atoms and optionally substituted as defined in the claims, Z' is a five- or six membered aromatic or heteroaromatic ring as defined in the claims, Y' is O or S.
Bibliography:Application Number: UA20030098173